Bain Capital Life Sciences Investors, LLC Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$894.2T
Holdings
31
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 3,577,267 | $164.4T | 18.39% | |
| 2 | PHVSPHARVARIS N V | 4,784,674 | $99.9T | 11.17% | |
| 3 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $96.9T | 10.83% | |
| 4 | SWTXSPRINGWORKS THERAPEUTICS INC | 3,081,307 | $71.2T | 7.97% | |
| 5 | IRONDISC MEDICINE INC | 1,332,545 | $62.6T | 7.00% | |
| 6 | YB4PSAVARA INC | 14,232,751 | $53.8T | 6.02% | |
| 7 | CRNXCRINETICS PHARMACEUTICALS IN | 1,275,552 | $37.9T | 4.24% | |
| 8 | TNGXTANGO THERAPEUTICS INC | 2,892,663 | $32.6T | 3.64% | |
| 9 | NTRANATERA INC | 700,197 | $31.0T | 3.46% | |
| 10 | CABACABALETTA BIO INC | 2,000,000 | $30.4T | 3.40% | |
| 11 | ACRSACLARIS THERAPEUTICS INC | 3,400,000 | $23.3T | 2.60% | |
| 12 | —EQRX INC | 10,003,573 | $22.2T | 2.48% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 15,960,588 | $17.4T | 1.95% | |
| 14 | ARQTARCUTIS BIOTHERAPEUTICS INC | 3,000,000 | $15.9T | 1.78% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 1,822,883 | $14.3T | 1.60% | |
| 16 | CBAYUSDCYMABAY THERAPEUTICS INC | 913,969 | $13.6T | 1.52% | |
| 17 | DVAXDYNAVAX TECHNOLOGIES CORP | 915,000 | $13.5T | 1.51% | |
| 18 | ANNXANNEXON INC | 5,701,926 | $13.5T | 1.50% | |
| 19 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $11.5T | 1.29% | |
| 20 | —MERSANA THERAPEUTICS INC | 8,663,673 | $11.0T | 1.23% | |
| 21 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $9.1T | 1.02% | |
| 22 | SYRSSYROS PHARMACEUTICALS INC | 2,124,694 | $8.4T | 0.94% | |
| 23 | SLDBSOLID BIOSCIENCES INC | 3,130,422 | $7.9T | 0.88% | |
| 24 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $7.5T | 0.83% | |
| 25 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $6.3T | 0.71% | |
| 26 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $5.9T | 0.66% | |
| 27 | TSVT*2SEVENTY BIO INC | 1,408,901 | $5.5T | 0.62% | |
| 28 | IVVDINVIVYD INC | 1,937,207 | $3.3T | 0.37% | |
| 29 | CCCCC4 THERAPEUTICS INC | 1,642,210 | $3.1T | 0.34% | |
| 30 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $190.0B | 0.02% | |
| 31 | CARAEURCARA THERAPEUTICS INC | 23,646 | $39.7B | 0.00% |